Skip to main content
OpenTrials

Clinical trial condition

Diphtheria

Explore clinical trials studying Diphtheria. Study availability and eligibility vary by location and protocol.

236 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Diphtheria trial results

Completed

Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)

NCT01453998

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations
  • GSK Investigational Site Santo Domingo, Dominican Republic
  • GSK Investigational Site Santo Domingo, Distrito Nacional, Dominican Republic
  • GSK Investigational Site Espoo, Finland
  • GSK Investigational Site Helsinki, Finland
View all 16 locations
View Trial Details
Completed

Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9

NCT00489970

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
Locations
  • GSK Investigational Site Huntsville, Alabama, United States
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site Mesa, Arizona, United States
View all 37 locations
View Trial Details
Completed

Evaluation of an Infant Immunization Encouragement Program in Nigeria

NCT03870061

Conditions
Actinomycetales Infections, Arbovirus Infections, Bacterial Infections, +55 more
Locations
  • Primary Health Care facilities across Jigawa State Various Cities, Jigawa State, Nigeria
  • Primary Health Care facilities across Katsina State Various Cities, Katsina State, Nigeria
  • Primary Health Care facilities across the Zamfara State Various Cities, Zamfara State, Nigeria
View Trial Details
Completed

Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines

NCT00148941

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
Locations
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Antioch, California, United States
  • GSK Investigational Site Daly City, California, United States
  • GSK Investigational Site Fairfield, California, United States
View all 24 locations
View Trial Details

Related conditions